Trials / Recruiting
RecruitingNCT04978948
Study of STIM1 Membrane Expression
Study of STIM1 Membrane Expression During Autoimmune Diseases
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 670 (estimated)
- Sponsor
- University Hospital, Brest · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to determine the expression of STIM1 in the plasma membrane of lymphocytes from patients suffering from different autoimmune diseases in order to identify new pathologies of interest presenting an over-expression of STIM1PM. This would allow to initiate, following this study, research and development programs on the use of anti-STIM1 antibodies in these identified autoimmune diseases of interest.
Conditions
Timeline
- Start date
- 2021-05-11
- Primary completion
- 2027-05-01
- Completion
- 2027-05-01
- First posted
- 2021-07-27
- Last updated
- 2025-02-06
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04978948. Inclusion in this directory is not an endorsement.